Although B7-H3 was initially characterized as a T cell co-stimulating protein, most recent studies have reported that B7-H3 is a T cell inhibitor that promotes tumor aggressiveness and proliferation (Picarda et al., 2016; Flem-Karlsen et al., 2018). This evidence concerns the gene CD276 and neoplasm.